Form 4 for IKT Inhibikase Therapeutics, Inc.
Accepted 2022-05-23 00:00:00 ET · period of report 2022-05-20 · accession 0000899243-22-019229 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-23 | 2022-05-20 | IKT | Werner Milton H. | Pres, CEO, Dir, 10% | P - Purchase | $0.6 | +10.0K | 5.33M | +0.2% | +$6,000 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-20 | P | A | 10,000 | $0.6 | 5,325,433 | D | — | — |